InvestorsHub Logo
Followers 30
Posts 2744
Boards Moderated 3
Alias Born 10/24/2015

Re: jondoeuk post# 34

Sunday, 05/16/2021 2:28:06 PM

Sunday, May 16, 2021 2:28:06 PM

Post# of 143
In April, the FDA approved a protocol amendment to the trial of NKX101. This includes an overall shorter waiting period between enrolment, an additional two-dose regimen to increase patient convenience and to deliver more CAR-NK cells earlier in each cycle, and the earlier introduction of non haplo-related, off-the-shelf NKX101 in the ongoing dose finding cohort. The company aims to present initial data by year end.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NKTX News